Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-16 · accession 0001470831-26-000186 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | 2026-02-16 | BBIO | Apuli Maricel | CAO | F - Tax | $75.25 | -4,349 | 124.5K | -3% | -$327.3K | |
| 2026-02-18 | 2026-02-17 | BBIO | Apuli Maricel | CAO | S - Sale | $74.31 | -510 | 123.9K | -0.4% | -$37.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-16 | F | D | 4,349 | $75.25 | 124,455 | D | — | — | (F1) Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 8,377 shares of Common Stock underlying the Reporting Person's RSUs. (F2) Includes 510 shares of the Issuer's Common Stock acquired by the Reporting Person on February 13, 2026 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. |
| 2 | Common | Common Stock | 2026-02-17 | S | D | 510 | $74.31 | 123,945 | D | — | — |